We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+8.73%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$301M
AUM Growth
+$19.7M
Cap. Flow
-$2.64M
Cap. Flow %
-0.88%
Top 10 Hldgs %
38.72%
Holding
58
New
2
Increased
3
Reduced
10
Closed
1

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$4.16M
2
ALC icon
Alcon
ALC
+$3.89M
3
AMZN icon
Amazon
AMZN
+$3.57M
4
ILMN icon
Illumina
ILMN
+$717K
5
ATR icon
AptarGroup
ATR
+$682K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$5.87M
2
MA icon
Mastercard
MA
+$3.27M
3
BIIB icon
Biogen
BIIB
+$2.79M
4
PEP icon
PepsiCo
PEP
+$1.09M
5
PYPL icon
PayPal
PYPL
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 26.75%
2 Technology 17.73%
3 Industrials 16.76%
4 Communication Services 11.07%
5 Consumer Discretionary 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$21.7M 7.22%
296,140
– –
MA icon
2
Mastercard
MA
$480B
$13.4M 4.44%
44,735
-11,590
-21% -$3.27M
PYPL icon
3
PayPal
PYPL
$49.9B
$13.2M 4.4%
122,380
-9,835
-7% -$1.02M
JNJ icon
4
Johnson & Johnson
JNJ
$609B
$11.7M 3.89%
80,370
-43,300
-35% -$5.87M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.23T
$10.5M 3.5%
157,200
-900
-0.6% -$58.1K
WM icon
6
Waste Management
WM
$96.1B
$9.76M 3.24%
85,625
– –
DHR icon
7
Danaher
DHR
$144B
$9.63M 3.2%
70,816
-84
-0.1% -$10.6K
ADI icon
8
Analog Devices
ADI
$183B
$9.18M 3.05%
77,270
– –
NSC icon
9
Norfolk Southern
NSC
$76.4B
$8.74M 2.9%
45,000
– –
XLNX
10
DELISTED
Xilinx Inc
XLNX
$8.68M 2.88%
88,805
– –
AMZN icon
11
Amazon
AMZN
$2.66T
$8.63M 2.87%
93,460
+40,300
+76% +$3.57M
ROK icon
12
Rockwell Automation
ROK
$51.4B
$8.53M 2.83%
42,070
– –
DIS icon
13
Walt Disney
DIS
$170B
$8.47M 2.81%
58,570
-55
-0.1% -$7.68K
ATR icon
14
AptarGroup
ATR
$8.46B
$8.24M 2.74%
71,275
+6,000
+9% +$682K
BSX icon
15
Boston Scientific
BSX
$65.4B
$7.51M 2.49%
166,015
– –
XYL icon
16
Xylem
XYL
$29.2B
$7.37M 2.45%
93,535
-90
-0.1% -$7K
ADP icon
17
Automatic Data Processing
ADP
$102B
$7.09M 2.35%
41,590
– –
PG icon
18
Procter & Gamble
PG
$349B
$7M 2.32%
56,025
– –
NKE icon
19
Nike
NKE
$64.9B
$6.9M 2.29%
68,110
– –
ABT icon
20
Abbott
ABT
$175B
$6.59M 2.19%
75,850
– –
NYT icon
21
New York Times
NYT
$12.3B
$6.26M 2.08%
194,650
– –
ILMN icon
22
Illumina
ILMN
$28.2B
$6M 1.99%
18,607
+2,365
+15% +$717K
AVGO icon
23
Broadcom
AVGO
$1.76T
$5.79M 1.92%
183,350
– –
MRK icon
24
Merck
MRK
$315B
$5.61M 1.86%
64,662
– –
HD icon
25
Home Depot
HD
$338B
$5.24M 1.74%
24,000
– –
1
2 3

Similar funds

RC
RBO & Co Saint Helena, California $620M AUM 4.67% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $620M AUM 16.24% 1-Year Est. Return
KFAS
Keating Financial Advisory Services Manhattan, Kansas $619M AUM
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
RIS
Richmond Investment Services Mequon, Wisconsin $619M AUM 22.39% 1-Year Est. Return
AMG
Asset Management Group Stamford, Connecticut $619M AUM 15.97% 1-Year Est. Return
BWP
Burling Wealth Partners Chicago, Illinois $618M AUM 17.33% 1-Year Est. Return
MC
McMorgan & Co San Francisco, California $618M AUM 8.76% 1-Year Est. Return

Chad R. Baker's Q4 2019 Portfolio in Review

As of Q4 2019, Chad R. Baker held 58 positions worth $301M, up 7% from $281M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Chad R. Baker's Q4 2019 filing shows 2 new, 3 increased, 10 reduced and 1 closed positions. Its largest new stake was CVS Health: 59,180 shares worth $4.4M. The largest sale was Johnson & Johnson, an estimated $5.87M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

  • Chad R. Baker's largest Q4 2019 buy was CVS Health: 59,180 shares worth $4.4M.
  • Chad R. Baker added most to Amazon in Q4 2019, an estimated $3.57M increase.
  • Chad R. Baker's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $5.87M.
  • Chad R. Baker fully exited Biogen in Q4 2019, selling an estimated $2.79M.
  • Chad R. Baker's ten largest holdings make up 39% of its $301M portfolio in Q4 2019.
  • Chad R. Baker opened 2 new positions and closed 1 in Q4 2019.
  • Chad R. Baker's portfolio value rose 7% quarter-over-quarter to $301M.

Based on Chad R. Baker's 13F filing for Q4 2019, filed 12 Feb 2020.